FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

Wyeth related Press Releases

Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region

Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region CHICAGO, Oct. 1 -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS) and Wyeth... Read more...

Wyeth Announces Major Adult Vaccine Clinical Trial for Pneumonia Prevention Begins

Wyeth Announces Major Adult Vaccine Clinical Trial for Pneumonia Prevention Begins - 85,000 Expected to Enroll in Phase 4 Study Initiated Pre-Registration - COLLEGEVILLE, Pa., Sept. 23 /PRNewswire/... Read more...

Amgen and Wyeth Statement on the FDA Safety Announcement Regarding Tumor Necrosis Factor (TNF) Blockers

Amgen and Wyeth Statement on the FDA Safety Announcement Regarding Tumor Necrosis Factor (TNF) Blockers THOUSAND OAKS, Calif. & COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Sept. 4, 2008--Amgen (NASDAQ:... Read more...

PRESS RELEASE: Raven biotechnologies and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies

Raven biotechnologies and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies SOUTH SAN FRANCISCO, Calif., Dec. 6 -- Raven biotechnologies, inc., a privately held company... Read more...

PRESS RELEASE: Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program

Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Children's Dimetapp Cold & Chest Congestion -- Dosage Cup Being Replaced, No... Read more...

PRESS RELEASE: Wyeth Jury Awards $99 Million Punitive Damages

Wyeth Jury Awards $99 Million Punitive Damages MADISON, N.J., Oct. 15 -- Wyeth confirmed today that it will appeal the verdict in the Scofield, Rowatt and Forrester v. Wyeth cases in the Second... Read more...

PRESS RELEASE: Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms

Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo COLLEGEVILLE, Pa., Oct. 15 -- Wyeth Pharmaceuticals, a... Read more...

PRESS RELEASE: Wyeth Acquires Haptogen to Boost Biotechnology Drug Discovery

Wyeth Acquires Haptogen to Boost Biotechnology Drug Discovery COLLEGEVILLE, Pa., Oct. 5 -- Wyeth Pharmaceuticals, a division of Wyeth, announced today the signing of a definitive agreement under... Read more...

PRESS RELEASE: Wyeth Announces Election of Bernard Poussot as CEO

Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1, 2008 Madison, N.J., September 27, 2007 — Wyeth today announced the election of Bernard Poussot to the position of... Read more...

PRESS RELEASE: Wyeth Osteoporosis Drug Succeeds in 3-Year Study

Wyeth Osteoporosis Drug Succeeds in 3-Year Study COLLEGEVILLE, Pa., Sept. 19 -- Wyeth Pharmaceuticals, a division of Wyeth , presented today the first Phase 3 fracture data for bazedoxifene, a... Read more...
12next ›last »